Skip to main content
Erschienen in: Supportive Care in Cancer 7/2016

02.02.2016 | Commentary

Addressing fear of recurrence: improving psychological care in cancer survivors

verfasst von: Christina Tomei, Sophie Lebel, Christine Maheu, Brittany Mutsaers

Erschienen in: Supportive Care in Cancer | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Fear of cancer recurrence (FCR) is defined as “the fear or worry that the cancer will return or progress in the same area or another part of the body.” FCR is associated with impaired functioning and lower quality of life in cancer patients. A cognitive-existential (CE) manualized group intervention for women with FCR showed a moderate effect size in reducing FCR, cancer-specific distress, and maladaptive coping. However, it appears that no individual intervention for FCR exists for both men and women. Therefore, the group intervention was adapted to an individual format.

Methods

This study was conducted to determine the feasibility, acceptability, and satisfaction of the individual intervention. The intervention was pilot-tested on n = 3 cancer survivors. The 6-week sessions included cognitive restructuring, structured exercises, and relaxation techniques. Participants completed questionnaire packages during a 4-week baseline period and throughout the 6-week intervention. Participants completed exit interviews following the intervention.

Results

General trends in baseline and intervention stages were compared. Based on the line graphs, the individual intervention appears to help survivors lower their elevated FCR and cancer-specific distress. Qualitative exit interviews conducted with the study participants demonstrated that the intervention was acceptable and satisfactory.

Conclusions

This clinical intervention allows researchers to systematically focus on evidence-based treatments for managing FCR, and displays the availability of treatment options in different therapeutic modalities. However, further research is needed to identify the active therapeutic ingredients and mechanisms of change in the intervention. Overall, intervention studies suggest it is possible to help cancer survivors manage their FCR.
Literatur
2.
Zurück zum Zitat Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S et al (2013) Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 7:300–322. doi:10.1007/s11764-013-0272-z CrossRefPubMed Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S et al (2013) Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 7:300–322. doi:10.​1007/​s11764-013-0272-z CrossRefPubMed
3.
Zurück zum Zitat Lee-Jones C, Humphris G, Dixon R, Hatcher MB (1997) Fear of cancer recurrence—a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology 6:95–105CrossRefPubMed Lee-Jones C, Humphris G, Dixon R, Hatcher MB (1997) Fear of cancer recurrence—a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology 6:95–105CrossRefPubMed
4.
Zurück zum Zitat Herschbach P, Berg P, Waadt S, Duran G, Engst-Hastreiter U, Henrich G et al (2010) Group psychotherapy of dysfunctional fear of progression in patients with chronic arthritis or cancer. Psychother Psychosom 79:31–38. doi:10.1159/000254903 CrossRefPubMed Herschbach P, Berg P, Waadt S, Duran G, Engst-Hastreiter U, Henrich G et al (2010) Group psychotherapy of dysfunctional fear of progression in patients with chronic arthritis or cancer. Psychother Psychosom 79:31–38. doi:10.​1159/​000254903 CrossRefPubMed
5.
Zurück zum Zitat Lebel S, Maheu C, Lefebvre M, Secord S, Courbasson C, Singh M et al (2014) Addressing fear of cancer recurrence among women with cancer: a feasibility and preliminary outcome study. J Cancer Surviv 8:485–496. doi:10.1007/s11764-014-0357-3 CrossRefPubMed Lebel S, Maheu C, Lefebvre M, Secord S, Courbasson C, Singh M et al (2014) Addressing fear of cancer recurrence among women with cancer: a feasibility and preliminary outcome study. J Cancer Surviv 8:485–496. doi:10.​1007/​s11764-014-0357-3 CrossRefPubMed
6.
Zurück zum Zitat Thewes B, Bell M, Smith A, Fardell J, Turner J, Butow P, the PoCoG FCR Working Group (2012) Conquer fear: the development and pilot testing of a novel psychological treatment for fear of cancer recurrence. Asia Pac J Clin Oncol 8:207 Thewes B, Bell M, Smith A, Fardell J, Turner J, Butow P, the PoCoG FCR Working Group (2012) Conquer fear: the development and pilot testing of a novel psychological treatment for fear of cancer recurrence. Asia Pac J Clin Oncol 8:207
7.
Zurück zum Zitat Butow P, Bell ML, Smith A B, Fardell JE, Thewes B, Turner J, Gilchrist J, Beith J, Girgis A, Sharpe L, Shih S, Mihalopolous C, members of the Conquer Fear Authorship Group (2013) Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence. BMC Cancer. doi: 10.1186/1471-2407-13-201 Butow P, Bell ML, Smith A B, Fardell JE, Thewes B, Turner J, Gilchrist J, Beith J, Girgis A, Sharpe L, Shih S, Mihalopolous C, members of the Conquer Fear Authorship Group (2013) Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence. BMC Cancer. doi: 10.1186/1471-2407-13-201
8.
Zurück zum Zitat van de Wal MA, Gielissen MFM, Servaes P, Knoop H, Speckens AEM, Prins JB (2015) Study protocol of the SWORD-study: a randomised controlled trial comparing combined online and face-to-face cognitive behaviour therapy versus treatment as usual in managing fear of cancer recurrence. BMC Psychology. doi: 10.1186/s40359-015-0068-1 van de Wal MA, Gielissen MFM, Servaes P, Knoop H, Speckens AEM, Prins JB (2015) Study protocol of the SWORD-study: a randomised controlled trial comparing combined online and face-to-face cognitive behaviour therapy versus treatment as usual in managing fear of cancer recurrence. BMC Psychology. doi: 10.1186/s40359-015-0068-1
9.
Zurück zum Zitat Carlson L, Tamagawa R, Stephen J, Doll R, Faris P, Dirkse D et al (2014) Tailoring mind-body therapies to individual needs: patients’ program preference and psychological traits as moderators of the effects of mindfulness-based cancer recovery and supportive-expressive therapy in distressed breast cancer survivors. J Natl Cancer Inst Monogr 50:308–314. doi:10.1093/jncimonographs/lgu034 CrossRef Carlson L, Tamagawa R, Stephen J, Doll R, Faris P, Dirkse D et al (2014) Tailoring mind-body therapies to individual needs: patients’ program preference and psychological traits as moderators of the effects of mindfulness-based cancer recovery and supportive-expressive therapy in distressed breast cancer survivors. J Natl Cancer Inst Monogr 50:308–314. doi:10.​1093/​jncimonographs/​lgu034 CrossRef
11.
Zurück zum Zitat Horowitz M, Wilner N, Alvarez W (1979) Impact of events scale: a measure of subjective stress. Psychosom Med 41:209–218CrossRefPubMed Horowitz M, Wilner N, Alvarez W (1979) Impact of events scale: a measure of subjective stress. Psychosom Med 41:209–218CrossRefPubMed
12.
Zurück zum Zitat Thewes B, Brebach R, Dzidowska M, Rhodes P, Sharpe L, Butow P (2014) Current approaches to managing fear of cancer recurrence; a descriptive survey of psychosocial and clinical health professionals. Psychooncology 23:390–396. doi:10.1002/pon.3423 CrossRefPubMed Thewes B, Brebach R, Dzidowska M, Rhodes P, Sharpe L, Butow P (2014) Current approaches to managing fear of cancer recurrence; a descriptive survey of psychosocial and clinical health professionals. Psychooncology 23:390–396. doi:10.​1002/​pon.​3423 CrossRefPubMed
Metadaten
Titel
Addressing fear of recurrence: improving psychological care in cancer survivors
verfasst von
Christina Tomei
Sophie Lebel
Christine Maheu
Brittany Mutsaers
Publikationsdatum
02.02.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 7/2016
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3103-8

Weitere Artikel der Ausgabe 7/2016

Supportive Care in Cancer 7/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.